Skip to main content

Krogulski Kenneth's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Jun 10, 2022

Accession no.
0001209191-22-035983
Filed
Jun 10, 2022
Trade date
May 2-29, 2022
Filing delay
39 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $5.53K. It was filed 39 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Krogulski KennethCIK 0001695580Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 2, 2022Common StockPPurchaseAcquired+101$2.45+$247.45185,311Direct
May 3, 2022Common StockPPurchaseAcquired+101$2.42+$244.42185,412Direct
May 4, 2022Common StockPPurchaseAcquired+101$2.37+$239.37185,513Direct
May 5, 2022Common StockPPurchaseAcquired+101$2.35+$237.35185,614Direct
May 6, 2022Common StockPPurchaseAcquired+101$2.36+$238.36185,715Direct
May 9, 2022Common StockPPurchaseAcquired+114$2.63+$299.82185,829Direct
May 10, 2022Common StockPPurchaseAcquired+114$2.55+$290.7185,943Direct
May 11, 2022Common StockPPurchaseAcquired+114$2.37+$270.18186,057Direct
May 12, 2022Common StockPPurchaseAcquired+114$2.23+$254.22186,171Direct
May 13, 2022Common StockPPurchaseAcquired+114$2.32+$264.48186,285Direct
May 16, 2022Common StockPPurchaseAcquired+114$2.31+$263.34186,399Direct
May 17, 2022Common StockPPurchaseAcquired+114$2.35+$267.9186,513Direct
May 18, 2022Common StockPPurchaseAcquired+114$2.31+$263.34186,627Direct
May 19, 2022Common StockPPurchaseAcquired+114$2.29+$261.06186,741Direct
May 20, 2022Common StockPPurchaseAcquired+114$2.23+$254.22186,855Direct
May 23, 2022Common StockPPurchaseAcquired+127$2.17+$275.59186,982Direct
May 24, 2022Common StockPPurchaseAcquired+127$2.17+$275.59187,109Direct
May 25, 2022Common StockPPurchaseAcquired+127$2.15+$273.05187,236Direct
May 26, 2022Common StockPPurchaseAcquired+127$2.12+$269.24187,363Direct
May 27, 2022Common StockPPurchaseAcquired+127$2.13+$270.51187,490Direct
May 29, 2022Common StockPPurchaseAcquired+127$2.13+$270.51187,617Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)